Also in this playlist...
This transcript is automatically generated
Blowing a diet this week or not take care of yourself don't worry about it because it's time for Sunday house call we're gonna help you out.
And joining us this morning is doctor David somebody the vice chairman of the department of urology cheaper products at the Mount Sinai Medical Center and up to mark single associate professor of medicine and -- lying on medical center in the author of the inner pulse.
Unlocking the secret code of sickness and health doctors as always good morning good morning guys and they over promised.
You -- hook people up with better health today great topic we will deliver -- Eric's first first -- edit some important Jamie details in the fight against Kenya.
There's an experimental treatment as she's done -- adults that actually sent their cancer into remission.
To -- some money this is really important sending -- -- into remission.
Eric this is a very interesting news that's coming up and very exciting for a lot of people listening we're talking about ALL.
Acute in the Pacific leukemia.
And it you know what what we know always it's a -- -- white blood cells that's a defense mechanism that's gold goes haywire.
And it turns into a cancer now has two peaks usually the children between age of two to five get this.
And that has a good prognosis about 80% of the kids do quite well with chemotherapy.
The next round is an older population.
And the prognosis is really pour about 30% of of population actually survive it despite chemotherapy.
Now the new way to do this is really the immune.
Therapy so we're going to use your own selves what we're doing is we're taking these -- -- -- white cells.
We inject them with harmless viruses and went through a genetic engineering.
We equip them.
That -- always -- can -- to find those cancer cells and kill them this is a very exciting news we're seeing this kind of defense and and therapy not just in leukemia but -- also other fields such as prostate cancer and breast and others so I think in the next.
Coming years they immunotherapy and ecological therapy it's gonna be about 75 billion dollar by 2015.
Very big news.
-- go to a doctor and obviously -- contest leukemia and and have it -- you how do you get it -- how do you.
What do you do about it also look at -- -- or generic -- you're not obviously not.
Getting it from what anyone else and as David said to get it mainly in childhood but we're very concerned today about adults that get it.
Because only 30% respond to initial treatment and it's miserable if they don't respond to initial treatment so what do you do next.
Now the wake chemotherapy works -- is simple you try to poison the cancer more than your poison the body and you attack rapidly growing cells.
The problem you can see what the problem is all the -- at least growing cells in the body are in trouble.
Your hair your bone marrow your GI tract your stomach those cells start to slow -- that's what you get all the side effects.
With targeted therapy and I MS health says we're going to be spending 75 billion dollars on this -- reporting fifteen.
That's the wave of the future in this case they took a cell that usually attacks viruses or attacks cancer -- AT -- They took it out of the body engineer put it back in.
And program it to attack cancer as though it's a foreign invader -- -- our problem with cancer is we don't see it as farm.
Now we see it is far and and that's why we had a tremendous response rate in people who already had not responded to therapy.
We've sent and the key war that that mark just mentioned was targeted therapy as opposed to chemotherapy which is a systemic point.
And of course is is -- first clinical trial we have about eight cases so far.
Fortunate news is that half of them are completely remission they're cured from this that's a huge news and half of them are partially.
In remission and they're going to get the bone marrow transplant.
So this is an ongoing we talked to the doctor two doctors say -- in from Sloan Kettering.
Who's going to really push this in -- cancer breast processes available now across the country it is in the go to touch -- body doctor now and Mike.
Get this not yet may not -- many cancer centers Dana Farber Sloan and others are really actually starting the clinical trial.
Just explain to folks targeted therapies where you take your own cells re engineer them and put them back vs the -- -- you're talking about which is a shelf item.
Same therapy for everybody different cocktails exactly right right good luck with everybody that's good news on leukemia and.
Filter by section